Gene Writers team

New Capabilities

Developer of the Vingi-1_Acar element described in the Cell paper

CAR-T therapy starts with a patient's T cells being removed, engineered in a lab and reinfused. A paper in Cell reports skipping the removal: engineered retrotransposons, delivered as RNA in lipid nanoparticles, inserted a receptor gene into T cells inside living mice.

Updated 1 hour ago